Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy

Purpose: To describe the diagnosis and management of a patient with primary open angle glaucoma (POAG) who developed suprachoroidal hemorrhage (SCH) after micropulse cyclophotocoagulation (MPCPC) therapy. Observations: A 77 year-old Caucasian man with end-stage POAG and multiple medical comorbiditie...

Full description

Bibliographic Details
Main Authors: Alisa J. Prager, Anupama R. Anchala
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993618303396
_version_ 1818287422828445696
author Alisa J. Prager
Anupama R. Anchala
author_facet Alisa J. Prager
Anupama R. Anchala
author_sort Alisa J. Prager
collection DOAJ
description Purpose: To describe the diagnosis and management of a patient with primary open angle glaucoma (POAG) who developed suprachoroidal hemorrhage (SCH) after micropulse cyclophotocoagulation (MPCPC) therapy. Observations: A 77 year-old Caucasian man with end-stage POAG and multiple medical comorbidities including coronary artery disease on anticoagulation presented with 2 days of episodic, severe left eye pain 2 weeks after undergoing MPCPC diode in the left eye. His visual acuity was count fingers at 2 feet and his intraocular pressure (IOP) was 44. He had a shallow anterior chamber that was open to trabecular meshwork on gonioscopy. His dilated fundus exam showed large, dome-shaped hemorrhagic choroidals, which were confirmed on ultrasound. He was medically managed with analgesics, cycloplegics, topical steroids and IOP lowering medications. He was closely followed with serial b-scans and the SCH decreased in size without surgical intervention, however, his visual acuity did not improve from presentation. Conclusions and importance: MPCPC diode has been increasingly used in refractory glaucoma and is considered to be a relatively safe procedure. Suprachoroidal hemorrhage has not yet been reported after MPCPC diode. This case demonstrates how devastating complications such as SCH can still occur with lower energy CPC therapy especially in the setting of post-procedural hypotony, and emphasizes the importance of prevention especially in high-risk patients.
first_indexed 2024-12-13T01:40:14Z
format Article
id doaj.art-b4fe7bdb7ac041e5bb0d8f55a532abe0
institution Directory Open Access Journal
issn 2451-9936
language English
last_indexed 2024-12-13T01:40:14Z
publishDate 2020-06-01
publisher Elsevier
record_format Article
series American Journal of Ophthalmology Case Reports
spelling doaj.art-b4fe7bdb7ac041e5bb0d8f55a532abe02022-12-22T00:03:47ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362020-06-0118Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapyAlisa J. Prager0Anupama R. Anchala1Department of Ophthalmology, Northwestern Feinberg School of Medicine, Chicago, IL, USACorresponding author. 645 N Michigan Avenue Suite 440 Chicago, IL, 60611, USA.; Department of Ophthalmology, Northwestern Feinberg School of Medicine, Chicago, IL, USAPurpose: To describe the diagnosis and management of a patient with primary open angle glaucoma (POAG) who developed suprachoroidal hemorrhage (SCH) after micropulse cyclophotocoagulation (MPCPC) therapy. Observations: A 77 year-old Caucasian man with end-stage POAG and multiple medical comorbidities including coronary artery disease on anticoagulation presented with 2 days of episodic, severe left eye pain 2 weeks after undergoing MPCPC diode in the left eye. His visual acuity was count fingers at 2 feet and his intraocular pressure (IOP) was 44. He had a shallow anterior chamber that was open to trabecular meshwork on gonioscopy. His dilated fundus exam showed large, dome-shaped hemorrhagic choroidals, which were confirmed on ultrasound. He was medically managed with analgesics, cycloplegics, topical steroids and IOP lowering medications. He was closely followed with serial b-scans and the SCH decreased in size without surgical intervention, however, his visual acuity did not improve from presentation. Conclusions and importance: MPCPC diode has been increasingly used in refractory glaucoma and is considered to be a relatively safe procedure. Suprachoroidal hemorrhage has not yet been reported after MPCPC diode. This case demonstrates how devastating complications such as SCH can still occur with lower energy CPC therapy especially in the setting of post-procedural hypotony, and emphasizes the importance of prevention especially in high-risk patients.http://www.sciencedirect.com/science/article/pii/S2451993618303396GlaucomaSuprachoroidal hemorrhageMicropulse cyclophotocoagulation diode
spellingShingle Alisa J. Prager
Anupama R. Anchala
Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy
American Journal of Ophthalmology Case Reports
Glaucoma
Suprachoroidal hemorrhage
Micropulse cyclophotocoagulation diode
title Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy
title_full Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy
title_fullStr Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy
title_full_unstemmed Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy
title_short Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy
title_sort suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy
topic Glaucoma
Suprachoroidal hemorrhage
Micropulse cyclophotocoagulation diode
url http://www.sciencedirect.com/science/article/pii/S2451993618303396
work_keys_str_mv AT alisajprager suprachoroidalhemorrhageaftermicropulsecyclophotocoagulationdiodetherapy
AT anupamaranchala suprachoroidalhemorrhageaftermicropulsecyclophotocoagulationdiodetherapy